Relapsed/Refractory Multiple Myeloma — Microlearning Activity 1 with Dr Sagar Lonial: ASH 2025 Review
Research To Practice | Oncology Videos · Dr. Neil Love
February 3, 202623m 23s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring an interview with Dr Sagar Lonial, including the following topics:
- KLN-1010: A novel, in vivo gene therapy generating anti-BCMA chimeric antigen receptor T cells (0:00)
- Phase III DREAMM-7 and DREAMM-8 studies of belantamab mafodotin-based combination therapy for patients with relapsed/refractory (R/R) multiple myeloma (MM) (5:37)
- Effectiveness of ciltacabtagene autoleucel for patients with R/R MM (11:04)
- Low-dose tocilizumab for mitigation of the cytokine release syndrome associated with bispecific antibodies (16:04)
- Talquetamab with teclistamab for patients with R/R MM in Phase Ib of the RedirecTT-1 trial (19:24)